Botanical guide · Ingredient reference

Pelargonium sidoides: respiratory symptom evidence and its scope

Keep named root extracts and symptom relief separate from general claims about killing infections.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

What the research addresses

Pelargonium sidoides root extracts are used for respiratory complaints. MSK describes clinical trials and reviews reporting improvements in some bronchitis and respiratory symptoms. These findings concern particular preparations and clinical settings, not every product using the plant name. [1]

What the finding does not establish

Symptom relief is different from proving that an infection has been eradicated or that future infections are prevented. Laboratory antiviral findings should not be presented as a substitute for that clinical evidence. [1]

Ask what “recovery” meant in the study

Suppose a trial measures a lower cough-symptom score after several days. An advertisement then claims the extract “eliminates the infection.” Those are different outcomes. To support the second claim, the study would need to measure and establish it rather than rely on the first.

A fair reading also asks what happened in the comparison group. Symptoms may improve over time without the tested product, so the difference between groups matters more than improvement within one group. Keep the extract, age group and measured time point beside the result.

Hypothetical example — illustrates evidence interpretation; not a product or dose recommendation.
Hypothetical finding or choiceWhat it means
Cough-symptom score improvesA symptom outcome
An infection is eliminatedA different endpoint requiring evidence
Only one group improves from baselineThe comparison-group change still matters

Safety and treatment considerations

Allergic reactions and gastrointestinal upset have been reported. The source also describes adverse symptoms in children, including worsening respiratory symptoms. A product studied in one age group or formulation should not be assumed appropriate for another without clinical advice. [1]

A practical next step

No pelargonium product or dosing schedule is recommended here. Persistent or worsening respiratory symptoms should be evaluated rather than managed by extending a supplement trial based on a broad immunity claim.

Pelargonium sidoides: respiratory symptom evidence and its scope — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Memorial Sloan Kettering Cancer Center — Pelargonium sidoides
    Source consulted: 2026-09-17. This is a reference resource, not a claim that we conducted the studies or tested a product.